Revised Document for the quarter and financial year ended on 31st March,2025 (Regulation 30 and 33 of the SEBI(Listing Obligation and Disclosure Requirement)Regulation,2015

pdf

Kimia Biosciences Ltd.

31 May 2025

36.93

2.58%

Company Update

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Corrigendum to Newspaper Publication of audited financial results for the quarter and year ended on 31, March 2025 ,dated 28.05.2025.

pdf

Kimia Biosciences Ltd.

29 May 2025

36.93

2.58%

Company Update

Kimia Biosciences Ltd - 530313 - Non-Applicability Of Regulation 24A Of SEBI(Listing Obligation And Disclosure ),Regulations,2015

BSE India

Non - Applicability of Regulation 24A of SEBI (Listing Obligation and Disclosure),Regulation ,2015

pdf

Kimia Biosciences Ltd.

28 May 2025

36.93

2.58%

Result

Kimia Biosciences Ltd - 530313 - Financial Results Ended On 31 March 2025

BSE India

Financial Results ended on 31 March 2025

pdf

Kimia Biosciences Ltd.

28 May 2025

36.93

2.58%

Company Update

Kimia Biosciences Ltd - 530313 - Newspaper Publication Of Financial Results As Per Regulation 30 Of …

BSE India

Newspaper Publication of Financial Results for the quarter and financial year ended on 31st Mrach,2025 as per Regulation 30 of Securities Exchange Board of India,2015

pdf

Kimia Biosciences Ltd.

26 May 2025

36.93

2.58%

Corp. Note

Kimia Biosciences Ltd - 530313 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and the financial year ended on 31st March 2025

pdf

Kimia Biosciences Ltd.

26 May 2025

36.93

2.58%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of The Financials In The …

BSE India

Outcome of the Financials in the Board Meeting

pdf

Kimia Biosciences Ltd.

23 May 2025

36.93

2.58%

Corp. Note

Kimia Biosciences Ltd - 530313 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKimia Biosciences Ltd 2CIN NO.L24239HR1993PLC032120 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 10.37 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: CS PALLAVI GARG Designation: COMPANY SECRETARY EmailId: compliance.kimiabiosciences@gmail.com Name of the Chief Financial Officer: Rakesh Chetani Designation: CFO EmailId: compliance.kimiabiosciences@gmail.com Date: 23/05/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Kimia Biosciences Ltd.

21 May 2025

36.93

2.58%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Approval Of Audited Financials For The …

BSE India

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve approval of audited financials for the quarter and financial year ended on 31st march 2025

pdf

Is Kimia Biosciences Ltd. worth buying?

14 Votes:

Buy 71.43%

Sell 7.14%

Hold 21.43%